Concepedia

Adila Izgutdina

AI

Statistics

Publications

4

Citations

80

H-Index

4

Active since

2023

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Chan Zuckerberg Initiative (United States)

University of San Francisco

University of Florida

Adila Izgutdina is an author at University of California, San Francisco specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2023–2025

4

Publications

4

Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target

Kamal Mandal, Gianina Wicaksono, Clinton Yu et al. · Nature Cancer · 2023 · 36 citations · Full text

, , +16

Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies

William C. Temple, Matthew A. Nix, Akul Naik et al. · Journal for ImmunoTherapy of Cancer · 2023 · 22 citations · Full text

, , +15

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar et al. · Blood · 2025 · 12 citations · Full text

, , +17

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 10 citations · Full text

, , +16

1–4 of 4